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Abstract: Two efficient methods for the amination of
2-halothiazoles are presented here. A first protocol
requires a Pd/L system. Several 2-aminothiazoles
were synthesized under optimized conditions and
isolated in good yields. The first palladium-catalyzed
CN coupling reactions between 2-halothiazoles and
primary alkylamines are presented. In a second part,
ligand-free copper-catalyzed aminations of 2-halo-
thiazoles by alkylamines and aniline in a green sol-
vent have been developed. The protocol is very ef-
fective for primary and secondary amines and per-
fectly tolerates the presence of another halide
moiety on the 2-halothiazole. The reaction occurs
under the assistance of microwave irradiation, which
drastically decreases the reaction time. The reaction
leads to the formation of 2-aminothiazoles, key
molecules in pharmaceutical research.
Keywords: 2-aminothiazoles; catalysis; CN cou-
pling; copper; microwaves; palladium
Introduction
Efficient synthesis of 2-aminothiazoles have attracted
a lot of attention since these compounds represent
powerful motifs in pharmaceutical research.[1] Rilu-
zole, for instance, has been used since decades in the
treatment of amyotrophic lateral sclerosis,[2] a fatal
and neurodegenerative disorder. R116010, meanwhile,
has been found as an efficient agent to inhibit the all-
trans-retinoic acid metabolism,[3] playing a role in the
differentiation and proliferation of epithelial tissues
(Figure 1).
Besides these applications, 2-aminothiazoles are
also key intermediates in the synthesis of numerous
biological molecules.[4] Classically, the amino moiety
is either already present or is introduced subsequently
via coupling or substitution reactions. Among the
most common strategies to form 2-aminothiazoles, nu-
cleophilic substitutions on 2-halothiazoles with
amines have been developed.[5] However, this method
generally requires long reaction times and harsh reac-
tion conditions which limits the reaction scope to re-
sistant amines. Isothiocyanates are also key precur-
sors, they can lead to 2-aminothiazoles by Cu(I)-[6] or
Fe ACHTUNGTRENNUNG(III)-catalyzed[7] cross-coupling reactions with 2-
haloanilines or can generate an intermediate with 2-
aminothiophenols which undergoes an oxidative cycli-
zation.[8] Palladium- or copper-catalyzed intramolecu-
lar cyclizations of 2-halobenzothioureas have also
been reported.[9] In contrast to the numerous Pd-cata-
lyzed CN coupling reactions reported in the litera-
ture[10] only six articles report on Pd-catalyzed aryla-
tion of 2-aminothiazoles.[11] Alternatively, the coupling
of an amine with a 2-halothiazole has been performed
with palladium[12] and copper.[13] Hartwig et al. , for ex-
ample, reported on a Pd ACHTUNGTRENNUNG(O2CCF3)2/P ACHTUNGTRENNUNG(t-Bu)3 system to
couple 2-halothiazoles and secondary amines.[12a]
Copper was used by Kaushik et al. for the catalytic N-
arylation of amines.[13a] The reaction was mediated by
CuI and performed in a CHCl3/H2O solvent systemFigure 1. Structures of Riluzole and R116010.
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which necessitates the addition of a phase-transfer
catalyst. Moreover, the reaction is limited to alkyl-
ACHTUNGTRENNUNGamines. To the best of our knowledge no direct palla-
dium-catalyzed couplings of 2-halothiazoles and pri-
mary alkylamines have been reported and Kaushik’s
catalyzed N-arylation of alkylamines is the only Cu-
mediated coupling reaction with 2-chlorothiazoles.
Most of the methods for the synthesis of 2-aminothia-
zoles require pre-made starting materials, drastic reac-
tion conditions or expensive catalytic systems and
generally provide environmentally hazardous waste.
Thus, it is of prime interest to develop direct synthetic
approaches applicable to thiazoles as an important
substrate class in pharmaceutical research[4] and con-
sequently the direct catalytic coupling between a 2-
halothiazole and an amine appears as the method of
choice. We report here on two different protocols for
the preparation of 2-aminothiazoles by either direct
palladium- or copper-catalyzed amination of 2-halo-
thiazoles with primary amines.
Results and Discussion
Palladium-Catalyzed Amination of Halothiazoles
When we started our investigations, various CN cou-
pling reactions had already been reported based on
Pd/Phosphine complexes.[10]
These strategies have shown a high correlation be-
tween the phosphine ligand employed and the sub-
strate. In fact, a careful ligand screening has to be per-
formed for optimization in order to get very efficient
coupling protocols adapted to each substrate. With
this fact in hand, we decided to screen different Pd/
ligand systems in order to find the most suitable one
for the CN coupling of primary amines with halo-
thiazoles. As model reaction the 2-chlorobenzothia-
zole 1a was submitted to the coupling in toluene with
isopropylamine 2a using NaO-t-Bu as base (Table 1).
First attempts were performed with Pd ACHTUNGTRENNUNG(OAc)2 (en-
tries 1 and 2) or Pd ACHTUNGTRENNUNG(dba)2 (entries 3 and 4) leading in
best cases to a 16% yield of 3a. Further attempts with
Pd ACHTUNGTRENNUNG(O2CCF3)2 and different phosphine ligands (en-
tries 5–9) led to low yields of the thiazole 3a, whereas
RuPhos (entry 10) or P ACHTUNGTRENNUNG(o-tolyl)3 (entry 11) afforded
the product in comparatively good yields. Finally, mi-
crowave irradiation and a Pd ACHTUNGTRENNUNG(O2CCF3)2/P ACHTUNGTRENNUNG(o-tolyl)3
catalyst system gave 64% of the desired product 3a
(entry 12). Without catalyst, no coupling has been ob-
served (entry 13).
The catalyst system Pd ACHTUNGTRENNUNG(O2CCF3)2/P ACHTUNGTRENNUNG(o-tolyl)3 was
then applied to the synthesis of several 2-aminothia-
zoles (Table 2). Amination of 1a with propylamine 2b
led to 3b in 62% yield (entry 1). The method tolerates
an increase of the alkyl chain by forming 3c and 3d
(entries 2 and 3) and the presence of a cyclic amine
yielding to 3e (entry 4). Benzothiazole 1a was also
successfully coupled with ethylenediamine 2f and led
only to the monoalkylated thiazole 3f in almost quan-
titative yield (entry 5). When applying these condi-
tions to the coupling with aniline (entry 6), aminothia-
zole 3g was not obtained when P ACHTUNGTRENNUNG(o-tolyl)3, P ACHTUNGTRENNUNG(t-Bu)3,
RuPhos or (o-biphen)PCy2 was used as ligands. Poor
yields of 3g were obtained with Xantphos, XPhos or
dppf and further attempts with Diphos or BrettPhos
led to more than 30% yield of 3g.
An increase of the temperature led to the forma-
tion of 43% of the expected product. When applying
microwave irradiation, thiazole 3g was obtained in
a good yield of 62%. BrettPhos revealed to be the
best performing ligand for this coupling as already ob-
served by Buchwald et al. in the case of other CN
coupling reactions with arylamines.[14] Despite several
attempts, this methodology could not be extended to
the coupling of 1a with other primary arylamines (see
the Supporting Information).
These amination protocols were then applied to the
coupling of 2-bromothiazole 4a and primary alkyl- or
arylamines. However, none of the expected amino-
thiazoles were formed in satisfactory yields. Even
under different Pd/phosphine catalytic system, 4a did
not undergo any coupling with primary amines.
In order to study if this intriguing difference of re-
activity between 1a and 4a is due to the substitution
Table 1. Amination of 2-chlorobenzothiazole via Pd/phos-
phine systems.[a]
Entry Pd Ligand Conditions Yield
[%][b]
1 PdACHTUNGTRENNUNG(OAc)2 PACHTUNGTRENNUNG(o-tolyl)3 22 8C/48 h –
2 PdACHTUNGTRENNUNG(OAc)2 PACHTUNGTRENNUNG(o-tolyl)3 60 8C/20 h 10
3 PdACHTUNGTRENNUNG(dba)2 PACHTUNGTRENNUNG(o-tolyl)3 22 8C/20 h 10
4 PdACHTUNGTRENNUNG(dba)2 PACHTUNGTRENNUNG(o-tolyl)3 40 8C/2 h
[c] 16
5 PdACHTUNGTRENNUNG(O2CCF3)2 PtBu3 22 8C/20 h 10
6 PdACHTUNGTRENNUNG(O2CCF3)2 dppf 22 8C/20 h –
7 PdACHTUNGTRENNUNG(O2CCF3)2 ACHTUNGTRENNUNG(o-biphen)PCy2 22 8C/20 h 5
8 PdACHTUNGTRENNUNG(O2CCF3)2 XPhos 22 8C/20 h 26
9 PdACHTUNGTRENNUNG(O2CCF3)2 Diphos 22 8C/20 h 31
10 PdACHTUNGTRENNUNG(O2CCF3)2 RuPhos 22 8C/20 h 57
11 PdACHTUNGTRENNUNG(O2CCF3)2 PACHTUNGTRENNUNG(o-tolyl)3 22 8C/20 h 62
12 PdACHTUNGTRENNUNG(O2CCF3)2 PACHTUNGTRENNUNG(o-tolyl)3 40 8C/2 h
[c] 64
13 – – 22 8C/48 h –
[a] Reaction conditions: 1a (1 mmol), 2a (4 mmol), Pd
(5 mol%), ligand (5 mol%), NaOtBu (1.1 mmol), toluene
(1 mL).
[b] Isolated yield.
[c] Reaction realized under microwave irradiation.
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pattern or to the nature of the halide, 1a was replaced
by its bromo analogue 1b and 4a was replaced by its
chloro analogue 4b. The thiazole 1b was coupled with
2a and 2g using the best previously determined condi-
tions (Table 3). The same method was applied to the
coupling with 4b. Only the base was changed, K3PO4
avoided the decomposition of 4b as observed in pres-
ence of NaO-t-Bu (Table 4).
These comparative studies underline the higher re-
activity of chlorothiazoles with respect to bromothia-
zoles which led to significantly better yields. A nucle-
ophilic substitution pathway, which would be consis-
tent with the reactivity profile, can be excluded, as no
reaction occurs in the absence of palladium (entry 13,
Table 1). In addition, Hartwig et al.[12a] and Buchwald
et al.[12b] have not used 2-bromobenzothiazole but 2-
chlorobenzothiazole in Pd-catalyzed CN couplings
with secondary amines. Some CC coupling reactions
have also been reported to be more efficient with 2-
chlorothiazoles compared to 2-bromothiazoles.[15]
The first part of this report describes the syntheses
of new 2-aminothiazoles based on the Pd-catalyzed
coupling of primary alkylamines or aniline and 2-
halo ACHTUNGTRENNUNGthiazoles. The choice of the ligand appears to be
a key parameter for the reaction as well as the nature
of the thiazole, 2-chlorothiazoles being more reactive
than their bromo analogues. We could perform vari-
ous coupling reactions of 2-chlorothiazoles and pri-
Table 2. Amination of 1a catalyzed by Pd ACHTUNGTRENNUNG(O2CCF3)2/PACHTUNGTRENNUNG(o-
tolyl)3.
[a]
Entry R Product Yield [%][b]
1 n-Pr 62
2 n-Bu 60
3 isopentyl 63
4 cyclohexyl 52
5 -(CH2)2NH2 97
6 Ph
–[c]
3[d]
8[e]
9[f]
31[g]
35[h]
43[i]
62[j]
[a] Reaction conditions: 1a (1 mmol), 2b–g (4 mmol), Pd (5
mol%), ligand (5 mol%), NaO-t-Bu (1.1 mmol), toluene
(1 mL), room temperature, 20 h.
[b] Isolated yield.
[c] PACHTUNGTRENNUNG(o-tolyl)3, P ACHTUNGTRENNUNG(t-Bu)3, RuPhos or (o-biphen)PCy2 used as
ligands.
[d] Xantphos as ligand.
[e] XPhos as ligand.
[f] dppf as ligand.
[g] Diphos as ligand.
[h] BrettPhos as ligand.
[i] BrettPhos as ligand, 100 8C, 20 h.
[j] BrettPhos as ligand, microwave irradiation: 40 8C, 3 h.
Table 3. Effect of the halobenzothiazole on the CN cou-
pling with primary amines.[a]
Entry Ligand RNH2 Condi ACHTUNGTRENNUNGtions Yield
[%][b]
Yield [%][b]
with 1a
1 PACHTUNGTRENNUNG(o-tolyl)3 i-PrNH2 40 8C/2 h
[c] 32 64
2 BrettPhos PhNH2 40 8C/2 h
[c] – 62
[a] Reaction conditions: 1b (1 mmol), RNH2 (4 mmol), Pd (5
mol%), ligand (5 mol%), NaO-t-Bu (1.1 mmol), toluene
(1 mL).
[b] Isolated yield.
[c] Reaction realized under microwave irradiation.
Table 4. Effect of the halothiazole on the CN coupling with
primary amines.[a]
Entry Ligand RNH2 Yield
[%][b]
Yield [%][b]
with 4a
1 PACHTUNGTRENNUNG(o-tolyl)3 i-PrNH2 77 8
2 BrettPhos PhNH2 – –
[a] Reaction conditions: 4b (1 mmol), RNH2 (4 mmol), Pd
(5 mol%), ligand (5 mol%), K3PO4 (1.1 mmol), toluene
(1 mL), 80 8C, 20 h.
[b] Isolated yield.
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mary alkylamines, however, in the case of arylamines
only aniline was reactive enough. The lack of reactivi-
ty of primary arylamines towards the coupling and
the important relation between the ligand and the
substrate prompted us to focus on more general meth-
ods to achieve this CN coupling. Recently, various
examples of Cu-catalyzed reactions have emerged in
the literature. Copper is for these kind of reactions
quite attractive due to its lower cost and lower toxici-
ty compared to palladium.[16] Ullmann-type couplings
are well known and documented especially with aryl
halides.[17] We therefore focused our attention to Cu-
catalyzed CN bond formations in order to enhance
the scope of the coupling between halothiazoles and
primary amines.
Copper-Catalyzed Amination of 2-Halothiazoles
Cheap copper salts, like CuI, revealed to be suitable
catalysts for C-N cross couplings.[18] Most frequently,
ligands have to be added in order to promote the re-
action. However, some ligand-free CN couplings
have been reported presenting the advantage to be
more atom economical processes than Pd-catalyzed
reactions.[19] First we applied the conditions reported
by Zeng et al. for the coupling of ortho-aminobenz-
ACHTUNGTRENNUNGenethiols and aryl ortho-dihalides.[20] 2-Bromobenzo-
thiazole 1b and aniline 2g were submitted to the cou-
pling reaction in presence of 30 mol% of CuI
(Scheme 1).
This protocol represents several advantages over
the Pd-catalyzed reactions: (i) use of a cheap CuI salt,
(ii) use of a green solvent (DMSO) and (iii) catalytic
amounts of copper (30 mol%). In this first attempt,
the aminothiazole 3g was obtained in 75% yield. As
bromothiazoles had been less reactive in the Pd-cata-
lyzed version of this coupling, we decided to run the
reaction using chlorothiazole 1a (Scheme 1).
The expected product was formed in a very good
93% yield. In this Cu-catalyzed version, 2-chloroben-
zothiazole 1a also seemed to be a better substrate
than its bromo analogue 1b. The following studies
have therefore been performed using 2-chlorothia-
zoles as coupling partners for amines. Despite several
attempts to improve the reaction conditions, it ap-
peared that this protocol (48 h at 120 8C) was the
most convenient one.
Next, these conditions were applied to the coupling
of 1a and 2a as an alkylamine (Table 5). Low yields
after prolonged heating were observed (entry 1). The
yields have been significantly increased under micro-
wave irradiation to 83% (entry 3). Finally, an increase
of the temperature under microwave assistance
formed the desired thiazole 3a in 94% yield (entry 4).
Without any copper no coupling has been observed
(entries 2 and 5). Encouraged by this result, we ex-
tended the scope of the coupling to several primary
alkylamines (Table 6). Prior attempts were realized
with the amines also used in the palladium-catalyzed
version (entries 1–4). Only propylamine (entry 1) led
to 3b in comparative yields to the Pd-catalyzed
system. Otherwise, copper revealed to be superior,
forming the aminothiazoles 3c, 3d and 3e in almost
quantitative yields (respectively entries 2, 3 and 4).
Applying the protocol to other substrates like isobu-
tylamine (entry 5), allylamine (entry 6) and benzyla-
mine (entry 7) demonstrated the efficiency of copper
to form 3h, 3i and 3j. The presence of an electron-do-
nating group like OMe at the ortho position of ben-
zylamine decreased the yield for 3k (entry 8), while
one at the para position tremendously increased it for
3l (entry 9). Although copper revealed to be the
metal of choice in terms of reactivity in the coupling
with primary alkylamines or aniline and in compari-
son with palladium, we are currently unable to extend
the scope to other primary arylamines (see the Sup-
porting Information). Chakraborti et al. have reported
Scheme 1. CN coupling reaction of 1b or 1a and PhNH2
catalyzed by CuI.
Table 5. Screening of conditions for the coupling of 2-chloro-
benzothiazole 1a and 2a catalyzed by CuI.[a]
Entry Conditions Yield [%][b]
1 120 8C, 48 h 13
2[c] 120 8C, 48 h 6
3 40 8C, 3 h[d] 83
4 100 8C, 3 h[d] 94
5[c] 100 8C, 3 h[d] –
[a] Reaction conditions: 1a (1 mmol), 2a (2 mmol), CuI
(30 mol%), K2CO3 (5 mmol), DMSO (3 mL).
[b] Isolated yield.
[c] Reaction realized without CuI.
[d] Reaction realized under microwave irradiation.
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solvent- and catalyst-free microwave-assisted nucleo-
philic substitutions between 2-chlorobenzothiazoles
and substituted anilines.[5d] The reactions needed
600 W in a domestic microwave to be achieved in
a few minutes. Attempts to reproduce the reaction
with 2-chlorobenzothiazole and aniline could not
have been performed due to the limit of 400 W and
250 8C of the microwave system.
Nevertheless, in a further approach, we decided to
keep on extending this scope to the synthesis of vari-
ous 2-aminothiazoles. Due to their importance in
pharmaceutical research, we studied the coupling re-
actions between 2-chlorothiazoles and various pri-
mary and secondary amines. In addition, we com-
pared thermal conditions (Method A) and microwave
irradiation (Method B) (Table 7). In general, Method
B revealed to be more efficient in these coupling re-
actions. However two exceptions were observed. The
first one concerned the reaction of 1a and methyl-
ACHTUNGTRENNUNGamine (entry1), where the yield of 9a was nearly
quantitative after a prolonged heating. A second one
was observed for the coupling of 1a and 8e, where
only Method A afforded in low yield the product 9e
(entry 5). A further reaction with 2-chlorobenzothia-
zole and 8b provided 9b in good yield (entry 2). Etha-
nolamine 8c afforded 9c only under microwave irradi-
ation (entry 3). A sterically more hindered amine
(entry 4), a cyclic one (entry 6) and pyrazole (entry 7)
led to the coupling products 9d, 9f and 9g in good
yields. 2-Chloro-6-fluorobenzothiazole 6 was also sub-
jected to the coupling with methyl-, ethyl- and phen-
ACHTUNGTRENNUNGethylamine (entries 8, 9 and 10) giving efficiently 10a,
10b and 10c. The coupling between piperidine
(entry 11) and pyrazole (entry 12) with 6 also afforded
10d and 10e in very good yields. The absence of any
coupling reaction at the 6 position of the thiazole 6
indicates that the protocol tolerates the presence of
an extra fluoride atom on the thiazole. With 2-chloro-
4-(4-chlorophenyl)thiazole 7 as substrate and methyl-,
ethylamine and pyrazole (entries 13–15) low yields
were obtained for 11a, 11b and 11c. No CN coupling
on the phenyl ring has been observed.
In summary, we have developed optimal micro-
wave-assisted conditions for the coupling of different
2-chlorothiazoles with primary and secondary amines,
affording 2-aminothiazoles as potential candidates for
pharmaceutical research.
Conclusions
The syntheses of novel 2-aminothiazoles via two tran-
sition metal-catalyzed CN coupling protocols be-
tween halothiazoles and amines have been developed.
A complete screening in palladium and phosphine li-
gands allowed us to determine optimum conditions
for the coupling of 2-chlorobenzothiazole with pri-
mary alkylamines. We also demonstrated that 2-
chloro ACHTUNGTRENNUNGthiazoles are much more efficient coupling
partners for aminations than their bromo analogues.
However, we were not able to extend this coupling to
other arylamines except aniline.
To achieve this aim, we focused therefore on the
catalytic coupling mediated by copper. A survey of
the conditions allowed us to synthesize numerous 2-
aminothiazoles under microwave irradiation. A com-
parison of the yields obtained with the copper-cata-
lyzed protocol and the palladium-catalyzed one dem-
onstrated the efficiency of the cheaper CuI salt. In ad-
dition, the ligand-free catalytic copper reactions are
Table 6. Scope of the CN coupling mediated by copper and
comparison with the palladium protocol.[a]
Entry RNH2 Product Yield [%]
[b,c]
1 n-Pr 57 (62)
2 n-Bu 97 (60)
3 isopentyl 99 (63)
4 cyclohexyl 98 (52)
5 i-Bu 92
6 allyl 42
7 Bn 42
8 2-(OMe)Bn 29
9 4-(OMe)Bn 92
[a] Reaction conditions: 1a (1 mmol), RNH2 (2 mmol), CuI
(30 mol%), K2CO3 (5 mmol), DMSO (3 mL), MW,
100 8C, 3 h.
[b] Isolated yield.
[c] In brackets, isolated yield obtained with the palladium
coupling (Table 4).
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Table 7. Scope of the CN couplings catalyzed by copper.[a]
Entry Thiazole R’R’’NH Product Yield [%][b] Method A[c] Yield [%][b] Method B[d]
1 96 55
2 84 84
3 – 38
4 75 92
5 23 -
6 93 92
7 74 74
8 96 98
9 81 96
10 53 70
11 93 93
12 73 82
13 <5 94
14 33 47
15 13 38
[a] Reaction conditions: 2-chlorothiazole (1 mmol), R’R’’NH (2 mmol), CuI (30 mol%), K2CO3 (5 mmol), DMSO (3 mL).
[b] Isolated yield.
[c] Method A: 120 8C, 48 h.[d] Method B: MW, 100 8C, 3 h.
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faster and are performed in a green solvent (DMSO),
placing the copper-catalyzed CN bond formation as
a method of choice to achieve the coupling between
2-chlorothiazoles and amines. We also demonstrated
that the copper-mediated reaction tolerates the pres-
ence of primary as well as secondary amines and can
be applied to 2-chlorothiazoles substituted by extra
halide atoms. Unfortunately, we were not able to
extend the coupling to the synthesis of aminoarylthia-
zoles, work which is currently in progress.
Experimental Section
Materials and Analysis
1H and 13C NMR spectra were acquired with a Bruker AM-
300 spectrometer at 300 and 75 MHz, respectively. 19F spec-
tra were acquired with a Bruker AM-400 spectrometer at
376 MHz. Chemical shifts are given on the delta scale as
parts per million (ppm) with tetramethylsilane (TMS) as the
internal standard. Column chromatography was performed
on silica gel. Microwave-assisted reactions were performed
in an Initiator 2.5 microwave system (Biotage, Inc.) at the
specified temperature using the standard mode of operation.
MS experiments were performed via a TOF spectrometer
equipped with an orthogonal electrospray (ESI) interface.
The reagents were purchased from commercial chemical re-
agent companies, and used without further purification
unless otherwise stated.
General Procedure for the Palladium-Catalyzed
Coupling Reactions between 2-Halobenzothiazoles
and Alkylamines
To a solution of Pd ACHTUNGTRENNUNG(O2CCF3)2 (0.05 mmol), P ACHTUNGTRENNUNG(o-tolyl)3
(0.05 mmol) and NaO-t-Bu (1.1 mmol) in toluene (1 mL) at
room temperature were added the 2-halobenzothiazole
(1 mmol) and the amine (4 mmol). The solution was stirred
at room temperature during 20 h. The reaction mixture was
then concentrated under reduced pressure. The residue was
purified by column chromatography on silica gel (eluting
with cyclohexane/AcOEt=4/1) to provide the desired ami-
nothiazole.
N-Isopropylbenzo[d]thiazol-2-amine (3a): Colorless solid.
1H NMR (300 MHz, CDCl3): d=1.32 (d, J=6.3 Hz, 6H),
3.85–4.00 (m, 1H), 5.33 (br. s, 1H), 7.07 (t, J=7.2 Hz, 1H),
7.28 (t, J=7.2 Hz, 1H), 7.52 (d, J=8.1 Hz, 1H), 7.57 (d, J=
7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=23.05, 47.62,
118.82, 120.73, 121.38, 125.88, 130.44, 152.56, 166.53; HR-
MS (ESI): m/z=193.078, calcd. for C10H12N2S [M+H]
+:
193.079.
N-Propylbenzo[d]thiazol-2-amine (3b): Colorless solid.
Characterization data were identical with the reported
data.[9e]
N-Butylbenzo[d]thiazol-2-amine (3c): Colorless solid.
Characterization data were identical with the reported
data.[21]
N-Isopentylbenzo[d]thiazol-2-amine (3d): Orange solid.
Characterization data were identical with the reported
data.[22]
N-cyclo-Hexylbenzo[d]thiazol-2-amine (3e): Colorless
solid. Characterization data were identical with the reported
data.[9e]
N1-(Benzo[d]thiazol-2-yl)ethane-1,2-diamine (3f): Color-
less solid. Characterization data were identical with the re-
ported data.[23]
General Procedure for the Palladium-Catalyzed
Coupling Reactions between 2-Halobenzothiazoles
(1a, 1b) and Aniline 2g
To a solution of Pd ACHTUNGTRENNUNG(O2CCF3)2 (0.05 mmol), BrettPhos
(0.05 mmol) and NaO-t-Bu (1.1 mmol) in toluene (1 mL) at
room temperature were added the 2-halobenzothiazole
(1 mmol) and the aniline (4 mmol). The solution was stirred
under microwave irradiation at 40 8C during 3 h. The reac-
tion mixture was then concentrated under reduced pressure.
The residue was purified by column chromatography on
silica gel (eluting with cyclohexane/AcOEt=4/1) to provide
the desired aminothiazole.
N-Phenylbenzo[d]thiazol-2-amine (3g): Colorless solid.
Characterization data were identical with the reported
data.[9e]
General Procedure for the Palladium-Catalyzed
Coupling Reactions between 2-Halothiazoles (4a, 4b)
and i-PrNH2 2a
To a solution of Pd ACHTUNGTRENNUNG(O2CCF3)2 (0.05 mmol), P ACHTUNGTRENNUNG(o-tolyl)3
(0.05 mmol) and K3PO4 (1.1 mmol) in toluene (1 mL) at
room temperature were added the 2-halothiazole (1 mmol)
and i-PrNH2 (4 mmol). The solution was stirred at 80 8C
during 20 h. The reaction mixture was then concentrated
under reduced pressure. The residue was purified by column
chromatography on silica gel (eluting with Cyclohexane/
AcOEt=4/1) to provide the desired aminothiazole.
N-Isopropylthiazol-2-amine (5a): Pale yellow solid.
1H NMR (300 MHz, CDCl3): d=1.28 (d, J=6.6 Hz, 6H),
3.66–3.77 (m, 1H), 5.03 (br. s, 1H), 6.48 (d, J=3.6 Hz, 1H),
7.10 (d, J=3.6 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=
22.88, 47.90, 106.24, 139.08, 169.42; HR-MS (ESI): m/z=
143.064, calcd. for C6H10N2S [M+H]
+: 143.064.
General Procedure for the Copper-Catalyzed
Coupling Reactions between 2-Halobenzothiazoles
and Amines
Method A: To a solution of CuI (0.3 mmol) and K2CO3
(5 mmol) in DMSO (5 mL) at room temperature were
added the 2-chlorothiazole (1 mmol) and the amine
(2 mmol). The solution was stirred at 120 8C during 48 h.
The reaction mixture was then diluted in 20 mL of AcOEt
and washed twice with portions of 20 mL of H2O. The aque-
ous layers were then extracted three times with portions of
20 mL of AcOEt. The organic layers were dried on Na2SO4,
filtered and concentrated under reduced pressure. The resi-
due was purified by column chromatography on silica gel
(eluting with cyclohexane/AcOEt=4/1) to provide the de-
sired aminothiazole.
Method B: To a solution of CuI (0.3 mmol) and K2CO3
(5 mmol) in DMSO (5 mL) at room temperature were
added the 2-chlorothiazole (1 mmol) and the amine
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(2 mmol). The solution was stirred under microwave irradia-
tion at 100 8C for 3 h. The reaction mixture was then diluted
in 20 mL of AcOEt and washed twice with portions of
20 mL of H2O. The aqueous layers were then extracted
three times with portions of 20 mL of AcOEt. The organic
layers were dried on Na2SO4, filtered and concentrated
under reduced pressure. The residue was purified by column
chromatography on silica gel (eluting with cyclohexane/
AcOEt=4/1) to provide the desired aminothiazole.
N-Isobutylbenzo[d]thiazol-2-amine (3h): Colorless solid.
1H NMR (300 MHz, CDCl3): d=1.01 (d, J=6.6 Hz, 6H),
1.91–2.02 (m, 1H), 3.23 (d, J=6.9 Hz, 2H), 5.50 (br. s, 1H),
7.07 (t, J=7.8 Hz, 1H), 7.29 (t, J=7.5 Hz, 1H), 7.52 (d, J=
8.1 Hz, 1H), 7.58 (d, J=7.2 Hz, 1H); 13C NMR (75 MHz,
CDCl3): d=20.12, 28.61, 53.28, 118.80, 120.75, 121.39,
125.94, 130.39, 152.55, 167.85; HR-MS (ESI): m/z=207.096,
calcd. for C11H14N2S [M+H]
+: 207.095.
6-Fluoro-N-methylbenzo[d]thiazol-2-amine (10a): Color-
less solid. 1H NMR (300 MHz, CDCl3): d=3.11 (s, 3H), 5.88
(br. s, 1H), 7.03 (td, J=9 Hz, J=2.4 Hz, 1H), 7.31 (dd, J=
8.1 Hz, J=2.7 Hz, 1H), 7.46 (dd, J=8.7 Hz, J=4.8 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=31.65, 107.59 (d,
2JF,C=
26.2 Hz, CH arom), 113.56 (d, 2JF,C=23.2 Hz, CH arom),
119.12 (d, 3JF,C=9 Hz, CH arom), 131.14 (d,
3JF,C=10.5 Hz,
C arom), 148.99, 158.16 (d, JF,C=237.7 Hz, C arom), 167.97;
19F NMR (376 MHz, CDCl3): d=121.56; HR-MS (ESI):
m/z=183.037, calcd. for C8H7N2S [M+H]
+: 183.039.
6-Fluoro-N-phenethylbenzo[d]thiazol-2-amine (10c): Col-
orless solid. 1H NMR (300 MHz, CDCl3): d=3.02 (t, J=
6.9 Hz, 2H), 3.71 (t, J=6.9 Hz, 2H), 5.30 (br. s, 1H), 7.03
(td, J=9.0 Hz, J=2.7 Hz, 1H), 7.24–7.37 (m, 6H), 7.46 (dd,
J=8.7 Hz, J=4.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=
35.53, 46.40, 107.55 (d, 2JF,C=27 Hz, CH arom), 113.56 (d,
2JF,C=23.2 Hz, CH arom), 119.36 (d,
3JF,C=9 Hz, CH arom),
126.80, 128.81, 131.19 (d, 3JF,C=10.5 Hz, C arom), 138.22,
148.93, 158.27 (d, JF,C=238.5 Hz, C arom), 166.52;
19F NMR
(376 MHz, CDCl3): d=121.30; HR-MS (ESI): m/z=
273.088, calcd. for C15H13FN2S [M+H]
+: 273.086.
6-Fluoro-2-(1H-pyrazol-1-yl)benzo[d]thiazole (10e): Col-
orless solid. 1H NMR (300 MHz, CDCl3): d=6.55 (m, 1H),
7.22 (td, J=9 Hz, J=2.7 Hz, 1H), 7.54 (dd, J=8.1 Hz, J=
2.7 Hz, 1H), 7.79 (m, 1H), 7.84 (dd, J=9 Hz, J=4.8 Hz,
1H), 8.46 (m, 1H); 13C NMR (75 MHz, CDCl3): d=108.13
(d, 2JF,C=27 Hz, CH arom), 109.42, 114.97 (d,
2JF,C=24.7 Hz,
CH arom), 123.28 (d, 3JF,C=9 Hz, CH arom), 127.83, 134.10
(d, 3JF,C=11.2 Hz, C arom), 143.41, 147.46, 159.90, 160.14 (d,
JF,C=243.7 Hz, C arom);
19F NMR (376 MHz, CDCl3): d=
116.02; HR-MS (ESI): m/z=242.019, calcd. for C10H6FN3S
[M+Na]+: 242.016.
4-(4-Chlorophenyl)-N-ethylthiazol-2-amine (11b): Pale
yellow solid. 1H NMR (300 MHz, CDCl3): d=1.28 (t, J=
7.2 Hz, 3H), 3.28–3.37 (m, 2H), 5.54 (br. s, 1H), 6.69 (s,
1H), 7.35 (d, J=8.7 Hz, 2H), 7.74 (d, J=8.7 Hz, 2H);
13C NMR (75 MHz, CDCl3): d=14.67, 40.79, 101.01, 127.29
(2C), 128.64 (2C), 133.23, 133.51, 150.41, 169.75; HR-MS
(ESI): m/z=239.039, calcd. for C11H11ClN2S [M+H]
+:
239.040.
4-(4-Chlorophenyl)-2-(1H-pyrazol-1-yl)thiazole (11c): Col-
orless solid. 1H NMR (300 MHz, CDCl3): d=6.52 (m, 1H),
7.25 (s, 1H), 7.43 (d, J=8.7 Hz, 2H), 7.76 (d, J=1.8 Hz,
1H), 7.86 (d, J=8.7 Hz, 2H), 8.44 (d, J=2.7 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=108.67, 109.49, 127.38 (2C),
127.47, 128.94 (2C), 132.50, 134.15, 142.79, 151.47, 161.15;
HR-MS (ESI): m/z=283.999, calcd. for C12H8ClN3S [M+
Na]+: 284.002.
N-Allylbenzo[d]thiazol-2-amine (3i): Pale yellow solid.
Characterization data were identical with the reported
data.[24]
N-Benzylbenzo[d]thiazol-2-amine (3j): Colorless solid.
Characterization data were identical with the reported
data.[8d]
N-(2-Methoxybenzyl)benzo[d]thiazol-2-amine (3k): Color-
less solid. Characterization data were identical with the re-
ported data.[8d]
N-(4-Methoxybenzyl)benzo[d]thiazol-2-amine (3l): Color-
less solid. Characterization data were identical with the re-
ported data.[8d]
N-Methylbenzo[d]thiazol-2-amine (9a): Colorless solid.
Characterization data were identical with the reported
data.[1a]
N-Ethylbenzo[d]thiazol-2-amine (9b): Colorless solid.
Characterization data were identical with the reported
data.[9e]
2-(Benzo[d]thiazol-2-ylamino)ethanol (9c): Colorless
solid. Characterization data were identical with the reported
data.[1a]
N-Phenethylbenzo[d]thiazol-2-amine (9d): Colorless
solid. Characterization data were identical with the reported
data.[22]
1-(Benzo[d]thiazol-2-yl)pyrrolidin-2-one (9e): Orange
solid. Characterization data were identical with the reported
data.[25]
2-(Piperidin-1-yl)benzo[d]thiazole (9f): Colorless solid.
Characterization data were identical with the reported
data.[8d]
2-(1H-Pyrazol-1-yl)benzo[d]thiazole (9g): Colorless solid.
Characterization data were identical with the reported
data.[26]
N-Ethyl-6-fluorobenzo[d]thiazol-2-amine (10b): Colorless
solid. Characterization data were identical with the reported
data.[7b]
6-Fluoro-2-(piperidin-1-yl)benzo[d]thiazole (10d): Color-
less solid. Characterization data were identical with the re-
ported data.[27]
4-(4-Chlorophenyl)-N-methylthiazol-2-amine (11a): Pale
yellow solid. Characterization data were identical with the
reported data.[28]
Acknowledgements
This work was supported by the Centre National de la Re-
cherche Scientifique (CNRS) and the University of Stras-
bourg. Merck KGaA is gratefully acknowledged for a post-
doctoral grant to S.T.
References
[1] a) A. D. Jordan, C. Luo, A. B. Reitz, J. Org. Chem.
2003, 68, 8693–8696; b) A. R. Katritzky, D. O. Tymosh-
enko, D. Monteux, V. Vvedensky, G. Nikonov, C. B.
Cooper, M. Deshpande, J. Org. Chem. 2000, 65, 8059–
3270 asc.wiley-vch.de  2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim Adv. Synth. Catal. 2013, 355, 3263 – 3272
FULL PAPERS Stphanie Toulot et al.
8062; c) R. A. Glennon, J. J. Gaines, M. E. Rogers, J.
Med. Chem. 1981, 24, 766–769.
[2] P. Jimonet, F. Audiau, M. Barreau, J.-C. Blanchard, A.
Boireau, Y. Bour, M.-A. Colno, A. Doble, G. Doerf-
linger, C. D. Huu, M.-H. Donat, J. M. Duchesne, P.
Ganil, C. Gurmy, E. Honor, B. Just, R. Kerphirique,
S. Gontier, P. Hubert, P. M. Laduron, J. Le Blevec, M.
Meunier, J.-M. Miquet, C. Nemecek, M. Pasquet, O.
Piot, J. Pratt, J. Rataud, M. Reibaud, J.-M. Stuzmann,
S. Mignani, J. Med. Chem. 1999, 42, 2828–2843.
[3] J. Van Heudsen, R. Van Ginckel, H. Bruwiere, P. Moe-
lans, B. Janssen, W. Floren, B. J. Van der Leede, J.
van Dun, G. Sanz, M. Venet, L. Dillen, C. Van Hove,
G. Willemsens, M. Janicot, W. Wouters, Br. J. Cancer
2002, 86, 605–611.
[4] a) C. Beaulieu, Z. Wang, D. Denis, G. Greig, S. Lamon-
tagne, G. ONeill, D. Slipetz, J. Wang, Bioorg. Med.
Chem. Lett. 2004, 14, 3195–3199; b) A. Kling, G. Back-
fisch, J. Delzer, H. Geneste, C. Graef, W. Hornberger,
U. Lange, A. Lauterbach, W. Seitz, T. Subkowski,
Bioorg. Med. Chem. 2003, 11, 1319–1341; c) F. Janssens,
J. Torremans, M. Janssen, R. A. Stokbroekx, M.
Luyckx, P. A. Janssen, J. Med. Chem. 1985, 28, 1925–
1933; d) M. S. Gomaa, J. L. Armstrong, B. Bobillon,
G. J. Veal, A. Brancale, C. P. F. Redfern, C. Simons,
Bioorg. Med. Chem. 2008, 16, 8301–8313; e) R. S. Cho-
pade, R. H. Bahekar, P. B. Khedekar, K. P. Bhusari,
A. R. R. Rao, Arch. Pharm. 2002, 335, 381–388; f) P.
Yogeeswari, D. Srisam, L. Suniljit, S. Kumar, J. Stables,
Eur. J. Med. Chem. 2002, 37, 231–236; g) P. Yogeeswari,
D. Sriram, S. Mehta, D. Nigam, M. M. Kumar, S. Muru-
gesan, J. Stables, Farmaco 2005, 60, 1–5; h) N. Siddiqui,
S. Pandeya, S. Khan, J. Stables, A. Rana, M. Alam, M.
Arshad, M. Bhat, Bioorg. Med. Chem. Lett. 2007, 17,
255–259; i) N. Siddiqui, A. Rana, S. Khan, M. Bhat, S.
Haque, Bioorg. Med. Chem. Lett. 2007, 17, 4178–4182.
[5] a) M. G. Saulnier, M. Dodier, D. B. Frennesson, D. R.
Langley, D. M. Vyas, Org. Lett. 2009, 11, 5154–5157;
b) K. Walczyn´ski, R. Guryn, O. P. Zuiderveld, H. Tim-
merman, Farmaco 1999, 54, 684–694; c) S. K. Anandan,
J. S. Ward, R. D. Brokx, T. Denny, M. R. Bray, D. V.
Patel, X. Y. Xiao, Bioorg. Med. Chem. Lett. 2007, 17,
5995–5999; d) H. F. Motiwala, R. Kumar, A. K. Chak-
raborti, Aust. J. Chem. 2007, 60, 369–374; e) M.
Schnrch, B. Waldner, K. Hilber, M. D. Mihovilovic,
Bioorg. Med. Chem. Lett. 2011, 21, 2149–2154.
[6] N. Khatun, L. Jamir, M. Ganesh, B. K. Patel, RSC Adv.
2012, 2, 11557–11565.
[7] a) J.-W. Qiu, X.-G. Zhang, R.-Y. Tang, P. Zhong, J.-H.
Li, Adv. Synth. Catal. 2009, 351, 2319–2323; b) Q. Ding,
B. Cao, X. Liu, Z. Zhong, Y. Peng, Green Chem. 2010,
12, 1607–1610.
[8] a) X. Zhang, X. Jia, J. Wang, X. Fan, Green Chem.
2011, 13, 413–423; b) R. Cano, D. J. Ramon, M. Yus, J.
Org. Chem. 2011, 76, 654–660; c) Y. Guo, R.-Y. Tang, P.
Zhong, J.-H. Li, Tetrahedron Lett. 2010, 51, 649–652;
d) E. Feng, H. Huang, Y. Zhou, D. Ye, H. Jiang, H.
Liu, J. Comb. Chem. 2010, 12, 422–429; e) D. Fajkuso-
va, P. Pazdera, Synthesis 2008, 1297–1305.
[9] a) C. Benedi, F. Bravo, P. Uriz, E. Fernandez, C.
Claver, S. Castillon, Tetrahedron Lett. 2003, 44, 6073–
6077; b) L. L. Joyce, G. Evindar, R. A. Batey, Chem.
Commun. 2004, 446–447; c) G. Evindar, R. A. Batey, J.
Org. Chem. 2006, 71, 1802–1808; d) J.-K. Wang, F.
Peng, J.-L. Jiang, Z.-J. Lu, L.-Y. Wang, J. F. Bai, Y. Pan,
Tetrahedron Lett. 2008, 49, 467–470; e) Q.-P. Ding, X.-
D. He, J. Wu, J. Comb. Chem. 2009, 11, 587–591;
f) G. D. Shen, X. Lv, W. L. Bao, Eur. J. Org. Chem.
2009, 5897–5901; g) J. Yang, P. Li, L. Wang, Tetrahedron
2011, 67, 5543–5549; h) P. Saha, T. Ramanna, N. Pur-
kait, M. A. Ali, R. Paul, T. Punniyamurthy, J. Org.
Chem. 2009, 74, 8719–8725; i) E. A. Jaseer, D. J. C.
Prasad, A. Dandapat, G. Sekar, Tetrahedron Lett. 2010,
51, 5009–5012.
[10] a) D. S. Surry, S. L. Buchwald, Angew. Chem. 2008, 120,
6438–6461; Angew. Chem. Int. Ed. 2008, 47, 6338–6361;
b) J. F. Hartwig, Nature 2008, 455, 314–322; c) I. P. Be-
letskaya, A. D. Averin, Pure Appl. Chem. 2004, 76,
1605–1619; d) J. F. Hartwig, Acc. Chem. Res. 2008, 41,
1534–1544; e) D. Audisio, S. Messaoudi, J.-F. Peyrat, J.-
D. Brion, M. Alami, Tetrahedron Lett. 2007, 48, 6928–
6932; f) X. Huang, K. W. Anderson, D. Zim, A. Kla-
pars, S. L. Buchwald, J. Am. Chem. Soc. 2003, 125,
6653–6655; g) F. Rataboul, A. Zapf, R. Jackstell, S.
Harkal, T. Riermeier, A. Monsees, U. Dingerdissen, M.
Beller, Chem. Eur. J. 2004, 10, 2983–2990; h) T. Schulz,
C. Torborg, S. Enthaler, B. Schffner, A. Dumrath, A.
Spannenberg, H. Neumann, A. Bçrner, M. Beller,
Chem. Eur. J. 2009, 15, 4528–4533.
[11] a) M. A. McGowan, J. L. Henderson, S. L. Buchwald,
Org. Lett. 2012, 14, 1432–1435; b) Q. Shen, T. Ogata,
J. F. Hartwig, J. Am. Chem. Soc. 2008, 130, 6586–6596;
c) W. J. Pitts, W. Vaccaro, T. Huynh, K. Leftheris, J. Y.
Roberge, J. Barbosa, J. Guo, B. Brown, A. Watson, K.
Donaldson, G. C. Starling, P. A. Kiener, M. A. Poss,
J. H. Dodd, J. C. Barrish, Bioorg. Med. Chem. Lett.
2004, 14, 2955–2958; d) J. Yin, M. M. Zhao, M. A. Huff-
man, J. M. McNamara, Org. Lett. 2002, 4, 3481–3484;
e) J. P. Schulte II, S. Tweedie, Synlett 2007, 15, 2331–
2336; f) M. Zhao, J. Yin, M. A. Huffman, J. M. McNa-
mara, Tetrahedron 2006, 62, 1110–1115.
[12] a) M. W. Hooper, M. Utsunomiya, J. F. Hartwig, J. Org.
Chem. 2003, 68, 2861–2873; b) M. D. Charles, P.
Schultz, S. L. Buchwald, Org. Lett. 2005, 7, 3965–3968;
c) Y. Hong, G. J. Tanoury, H. S. Wilkinson, R. P.
Bakale, S. A. Wald, C. H. Senanayake, Tetrahedron
Lett. 1997, 38, 5607–5610; d) D. Samson, E. Daltrozzo,
Helv. Chim. Acta 2011, 94, 46–60.
[13] a) S. K. Verma, B. N. Acharya, M. P. Kaushik, Org.
Biomol. Chem. 2011, 9, 1324–1327; b) V. S. C. Yeh, P. E.
Wiedeman, Tetrahedron Lett. 2006, 47, 6011–6016.
[14] a) B. P. Fors, D. A. Watson, M. R. Biscoe, S. L. Buch-
wald, J. Am. Chem. Soc. 2008, 130, 13552–13554;
b) B. P. Fors, N. R. Davis, S. L. Buchwald, J. Am. Chem.
Soc. 2009, 131, 5766–5768.
[15] a) L. Lu, H. Yan, P. Sun, Y. Zhu, H. Yang, D. Liu, G.
Rong, J. Mao, Eur. J. Org. Chem. 2013, 2013, 1644–
1648; b) D. P. Ojha, K. R. Prabhu, J. Org. Chem. 2012,
77, 11027–11033; c) S. Saleh, M. Picquet, P. Meunier, J.-
C. Hierso, Tetrahedron 2009, 65, 7146–7150.
[16] A. J. Hickman, M. S. Sanford, Nature 2012, 484, 177–
185.
[17] a) F. Wang, S. Cai, L. Qian, C. Xi, J. Org. Chem. 2011,
76, 3174–3180; b) Q. Cai, Z. Li, J. Wei, L. Fu, C. Ha, D.
Adv. Synth. Catal. 2013, 355, 3263 – 3272  2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim asc.wiley-vch.de 3271
Convenient and Reliable Routes Towards 2-Aminothiazoles
Pei, K. Ding, Org. Lett. 2010, 12, 1500–1503; c) J. T.
Reeves, D. R. Fandrick, Z. Tan, J. J. Song, H. Lee, N. K.
Yee, C. H. Senanayake, J. Org. Chem. 2010, 75, 992–
994; d) X. Liu, H. Fu, Y. Jiang, Y. Zhao, Angew. Chem.
2009, 121, 354–357; Angew. Chem. Int. Ed. 2009, 48,
348–351; e) F. Wang, H. Liu, H. Fu, Y. Jiang, Y. Zhao,
Org. Lett. 2009, 11, 2469–2472; f) X. Lv, W. Bao, J. Org.
Chem. 2009, 74, 5618–5621; g) J. Zhu, H. Xie, Z. Chen,
S. Li, Y. Wu, Chem. Commun. 2009, 2338–2340; h) A.
Minatti, S. Buchwald, Org. Lett. 2008, 10, 2721–2724;
i) B. Wang, B. Lu, Y. Jiang, Y. Zhang, D. Ma, Org. Lett.
2008, 10, 2761–2763.
[18] a) Q. Liao, L. Zhang, S. Li, C. Xi, Org. Lett. 2010, 13,
228–231; b) D. Chen, G. Shen, W. Bao, Org. Biomol.
Chem. 2009, 7, 5618–5621.
[19] a) P. Sang, Y. Xie, J. Zou, Y. Zhang, Org. Lett. 2012, 14,
3894–3897; b) D. Guo, H. Huang, Y. Zhou, J. Xu, H.
Jiang, K. Chen, H. Liu, Green Chem. 2010, 12, 276–
281; c) L. Zhu, G. Li, L. Luo, P. Guo, J. Lan, J. You, J.
Org. Chem. 2009, 74, 2200–2202; d) X.-F. Wu, C.
Darcel, Eur. J. Org. Chem. 2009, 4753–4756; e) M. Tail-
lefer, N. Xia, A. Ouali, Angew. Chem. 2007, 119, 952–
954; Angew. Chem. Int. Ed. 2007, 46, 934–936; f) K.
Okano, H. Tokuyama, T. Fukuyama, Org. Lett. 2003, 5,
4987–4990.
[20] C. Dai, X. Sun, X. Tu, L. Wu, D. Zhan, Q. Zeng, Chem.
Commun. 2012, 48, 5367–5369.
[21] Y. L. Sun, Y. Zhang, X.-H. Cui, W. Wang, Adv. Synth.
Catal. 2011, 353, 1174–1178.
[22] F. Li, H. Shan, L. Chen, Q. Kang, P. Zou, Chem.
Commun. 2012, 48, 603–605.
[23] L. Ouyang, Y. Huang, Y. Zhao, G. He, Y. Xie, J. Liu, J.
He, B. Liu, Y. Wei, Bioorg. Med. Chem. Lett. 2012, 22,
3044–3049.
[24] S.-G. Kim, S.-L. Jung, G.-H. Lee, Y.-D. Gong, ACS
Comb. Sci. 2013, 15, 29–40.
[25] S. Mitsuda, T. Fujiwara, K. Kimigafukuro, D. Mongu-
chi, A. Mori, Tetrahedron 2012, 68, 3585–3590.
[26] X. Deng, A. Roessler, I. Brdar, R. Faessler, J. Wu, Z. S.
Sales, N. S. Mani, J. Org. Chem. 2011, 76, 8262–8269.
[27] D. Ma, X. Lu, L. Shi, H. Zhang, Y. Jiang, X. Liu,
Angew. Chem. 2011, 123, 1150–1153; Angew. Chem.
Int. Ed. 2011, 50, 1118–1121.
[28] S. N. Dighe, P. K. Chaskar, K. S. Jain, M. S. Phoujdar,
K. V. Srinivasan, ISRN Org. Chem. 2011, 2011, 1–6.
3272 asc.wiley-vch.de  2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim Adv. Synth. Catal. 2013, 355, 3263 – 3272
FULL PAPERS Stphanie Toulot et al.
